homotaurine
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
1
Earliest trial started Jan 25, 2018 (NCT04422743)
Timeline
Indications
Approved for
Mechanism of action
- Beta amyloid A4 proteinINHIBITOR
APP inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06431113 | Phase 3 | Jan 27, 2024 | University of Naples Frederico II, University of Pavia, University of Roma La Sapienza |
| NCT05022186 | Phase 4 | Apr 1, 2021 | Aristotle University of Thessaloniki, Greek Alzheimer's Association and Related Disorders |
| NCT04422743 | Phase 2 | Jan 25, 2018 | Foundation IRCCS San Matteo Hospital, University of Pavia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pavia | Academic/Hospital | 2 | 2 | 2 | 2018 |
| Aristotle University of Thessaloniki | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Foundation IRCCS San Matteo Hospital | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Greek Alzheimer's Association and Related Disorders | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Naples Frederico II | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 0 | 1 | 2024 |
6 organizations
Page 1 / 1